had been a medicine however, the pharmacist change) e.g. within 4 undertaking the MUR weeks; has an ethical responsibility to address (d) Are taking or inappropriate selection, about to commence prescribing or use of taking medicine(s) medicine if identified. with a high risk of adverse effects; The consultation is conducted by a (e) With a particular pharmacist with the medicine related patient and intervention problem e.g. adverse is largely at the patient reaction, level. The service often involves four quarterly consultations between (f) Experience or are the pharmacist and at risk of experiencing patient and the sub-optimal response pharmacist must have to pharmacotherapy; access to the patient’s medication profile but (g) Are non-adherent not necessarily their or unable to manage clinical information. It their medicines; must be conducted in a private area. It involves a (h) Have difficulty review of and counselling managing their about all current medicines due to, for medicines, assessment of
had been a medicine change) e.g. within 4 weeks; (d) Are taking or about to commence taking medicine(s) with a high risk of adverse effects; (e) With a particular medicine related problem e.g. adverse reaction, (f) Experience or are at risk of experiencing sub-optimal response to pharmacotherapy; (g) Are non-adherent or unable to manage their medicines; (h) Have difficulty managing their medicines due to, for however, the pharmacist undertaking the MUR has an ethical responsibility to address inappropriate selection, prescribing or use of medicine if identified. The consultation is conducted by a pharmacist with the patient and intervention is largely at the patient level. The service often involves four quarterly consultations between the pharmacist and patient and the pharmacist must have access to the patient’s medication profile but not necessarily their clinical information. It must be conducted in a private area. It involves a review of and counselling about all current medicines, assessment of